PCRX CIK: 1396814

Pacira BioSciences, Inc.

  • United States
  • Healthcare
  • Pharma
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
401
FY22:
468
FY23:
490
FY24:
531
FY25:
577
(positive)
Change from FY21 to FY25
millions USD
FY21:
89.9
FY22:
60.0
FY23:
87.7
FY24:
−73.4
FY25:
19.2
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
123
(positive)
Change from FY21 to FY25
millions USD
FY21:
56.4
FY22:
13.3
FY23:
61.7
FY24:
−63.1
FY25:
16.9
(positive)
Change from FY21 to FY25
millions USD
FY21:
42.0
FY22:
15.9
FY23:
42.0
FY24:
−99.6
FY25:
7.03

All amounts in millions USD Data sources:SEC EDGARTwelve Data